首页|HSCT治疗患者相关腹泻发生的现状调查及影响因素研究

HSCT治疗患者相关腹泻发生的现状调查及影响因素研究

扫码查看
目的 分析造血干细胞移植(hematopoietic stem cell transplantation,HSCT)患者发生腹泻的影响因素,为临床预防提供指导。方法 回顾性分析厦门大学附属第一医院2022年1月—2023年12月90例HSCT治疗患者的临床资料,根据患者在治疗过程中是否发生腹泻分为腹泻组60例为正常组30例。分析患者发生腹泻与一般资料(性别、年龄、文化程度、职业、婚姻状况、原发病)、移植情况(移植次数、移植类型、移植时间)、是否发生并发症、锻炼自我效能、焦虑、抑郁、社会支持、疲乏评分的关系,采用多因素logistic回归模型分析腹泻发生的危险因素。结果 90例HSCT患者中,有60例患者发生腹泻,占比为66。67%。其中,移植次数、移植类型、移植时间、有无并发症、锻炼自我效能是影响HSCT患者发生腹泻的单因素(P<0。05)。多因素logistic回归分析结果显示,移植类型为非自体移植(OR=1。571,95%CI 1。011~2。442,P=0。045)是影响HSCT患者发生腹泻的独立危险因素,移植次数1次(OR=0。950,95%CI 0。923~0。979,P<0。001)、移植时间短(OR=0。742,95%CI 0。638~0。863,P<0。001)、无并发症(OR=0。909,95%CI 0。842~0。982,P=0。015)则为保护因素。结论 移植类型为非自体移植是提升HSCT患者发生腹泻风险的独立危险因素,移植次数1次、移植时间短、无并发症是降低HSCT患者发生腹泻风险的保护因素,可提前采取相关措施预防HSCT治疗相关腹泻的发生。
Current Situation Investigation of Diarrhea Occurrence and Study of Influencing Factors in Patients Treated With HSCT
Objective To analyze the influencing factors of diarrhea occurrence in patients with hematopoietic stem cell transplantation (HSCT),and to provide guidance for clinical prevention. Methods A total of 90 patients with HSCT in the First Affiliated Hospital of Xiamen University were retrospectively analyzed from January 2022 to December 2023. According to whether diarrhea occurred during treatment,the patients were divided into 60 cases in diarrhea group and 30 cases in normal group. The relationship between diarrhea occurrence and general data (gender,age,education level,occupation,marital status,primary disease),transplant status (number,type,and time of transplantation),whether complications occurred,exercise self-efficacy,anxiety,depression,social support,and fatigue score were analyzed. Multivariate logistic regression model was used to analyze the risk factors of diarrhea. Results Among the 90 patients with HSCT,60 patients had diarrhea,accounting for 66.67%. The transplantation number,transplant type,transplantation time,presence or absence of complications and exercise self-efficacy were the single factors affecting the occurrence of diarrhea in HSCT patients (P<0.05). Multivariate logistic regression analysis showed that transplantation type being non autologous (OR=1.571,95%CI 1.011-2.442,P=0.045) was an independent risk factor for diarrhea in HSCT patients,and the number of one transplant (OR=0.950,95%CI 0.923-0.979,P<0.001),short transplantation time (OR=0.742,95%CI 0.638-0.863,P<0.001),and absence of complications (OR=0.909,95%CI 0.842-0.982,P=0.015) were protective factors. Conclusion Transplantation type being non autologous is an independent risk factor for increasing the risk of diarrhea in HSCT patients,and the number of one transplant,short transplantation time and absence of complications are protective factors for reducing the risk of diarrhea in HSCT patients. It is necessary to take relevant measures in advance to prevent the occurrence of HSCT treatment-related diarrhea.

hematopoietic stem cell transplantationdiarrheastatus surveyinfluencing factorslogistic regression analysispreventive measures

林珠豆、邓漫漫、林莽市

展开 >

厦门大学附属第一医院血液科,福建 厦门 361000

厦门大学附属第一医院杏林分院骨科,福建 厦门 361000

造血干细胞移植 腹泻 现状调查 影响因素 logistic回归分析 预防措施

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(20)